Equities analysts forecast that Medley Capital Corp (NYSE:MCC) will post $15.43 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Medley Capital’s earnings, with estimates ranging from $14.06 million to $16.79 million. Medley Capital reported sales of $22.15 million in the same quarter last year, which indicates a negative year-over-year growth rate of 30.3%. The firm is expected to issue its next quarterly earnings report on Thursday, December 6th.
According to Zacks, analysts expect that Medley Capital will report full year sales of $67.04 million for the current year, with estimates ranging from $65.67 million to $68.40 million. For the next fiscal year, analysts expect that the company will post sales of $65.48 million, with estimates ranging from $62.77 million to $68.18 million. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that follow Medley Capital.
Medley Capital (NYSE:MCC) last announced its quarterly earnings results on Thursday, August 9th. The investment management company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by ($0.08). Medley Capital had a negative net margin of 134.96% and a positive return on equity of 5.03%. The firm had revenue of $13.95 million during the quarter, compared to analyst estimates of $18.23 million.
Shares of MCC stock traded down $0.04 on Wednesday, hitting $3.60. The stock had a trading volume of 64,279 shares, compared to its average volume of 173,965. Medley Capital has a twelve month low of $3.35 and a twelve month high of $5.88. The firm has a market capitalization of $196.65 million, a price-to-earnings ratio of 5.37 and a beta of 1.06. The company has a quick ratio of 11.00, a current ratio of 11.00 and a debt-to-equity ratio of 1.21.
Several hedge funds have recently made changes to their positions in the company. BlackRock Inc. grew its holdings in shares of Medley Capital by 9.4% in the 3rd quarter. BlackRock Inc. now owns 264,349 shares of the investment management company’s stock valued at $1,010,000 after buying an additional 22,621 shares during the period. JPMorgan Chase & Co. boosted its stake in Medley Capital by 118.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 59,902 shares of the investment management company’s stock worth $229,000 after purchasing an additional 32,539 shares during the period. PFG Advisors acquired a new position in Medley Capital in the 3rd quarter worth $204,000. Highland Capital Management LP acquired a new position in Medley Capital in the 2nd quarter worth $339,000. Finally, Raymond James & Associates acquired a new position in Medley Capital in the 2nd quarter worth $187,000. 25.42% of the stock is owned by institutional investors.
About Medley Capital
Medley Capital Corporation is a business development company. The fund seeks to invest in privately negotiated debt and equity securities of small and middle market companies. It primarily invests in the following sectors: business services; buildings and real estate; automobile; oil and gas; aerospace and defense; home and office furnishings, housewares, and durable consumer products; healthcare, education and childcare; personal, food, and miscellaneous services; retail stores, diversified or conglomerate manufacturing; telecommunications; mining, steel, iron, and non-precious metals; leisure, amusement, motion pictures, and entertainment; chemicals, plastics, and rubber; finance; personal and nondurable consumer products (manufacturing only); beverage, food, and tobacco; containers, packaging, and glass; structure finance securities; machinery (non-agriculture, non-construction, non-electric); diversified or conglomerate service; restaurant and franchise; electronics; and cargo transport.
Recommended Story: What is the yield curve?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medley Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medley Capital and related companies with MarketBeat.com's FREE daily email newsletter.